Work

Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participants

Year: 2021

Type: article

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(21)00377-6

Authors: Morgan A Casal, S Percy Ivy, Jan H Beumer, Thomas D Nolin

Institutions: University of Pittsburgh, National Cancer Institute, UPMC Health System, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

Language: English

Topic: Chronic Kidney Disease and Diabetes

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, National Institutes of Health, National Cancer Institute

Awards: G1136802065, G2501690305, G2768429814, G5294865689, Clinical Trials Monitoring Service, G6794994719, G7111393289, NCI ETCTN Pittsburgh Cancer Consortium (PCC), PITT-CAL ETCTN PK Resource Laboratory, Cancer Center Support Grant

OpenAlex ID: W3193807166

FWCI: 6.679

Cites: 35

Cited by: 47

Related to: 10